Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data

High effectiveness and safety of beta-adrenoblockers (BB) in patients with coronary heart disease (CHD) have been proven by manifold clinical trials. BB are effective and safe, provided dose regimen is correct and contraindications are taken into account. BB significantly reduce total mortality and...

Full description

Bibliographic Details
Main Authors: A. E. Radzevich, A. G. Evdokimova, A. Yu. Konyakhin, V. V. Popov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1505
_version_ 1797882872513691648
author A. E. Radzevich
A. G. Evdokimova
A. Yu. Konyakhin
V. V. Popov
author_facet A. E. Radzevich
A. G. Evdokimova
A. Yu. Konyakhin
V. V. Popov
author_sort A. E. Radzevich
collection DOAJ
description High effectiveness and safety of beta-adrenoblockers (BB) in patients with coronary heart disease (CHD) have been proven by manifold clinical trials. BB are effective and safe, provided dose regimen is correct and contraindications are taken into account. BB significantly reduce total mortality and sudden cardiac death risk in CHD patients.
first_indexed 2024-04-10T03:41:33Z
format Article
id doaj.art-55fdc54d8bdc4d339d279f2960eb0a6e
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:41:33Z
publishDate 1970-01-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-55fdc54d8bdc4d339d279f2960eb0a6e2023-03-13T07:23:08Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-01771051151223Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine dataA. E. Radzevich0A. G. Evdokimova1A. Yu. Konyakhin2V. V. Popov3Московский государственный медико-стоматологический университет Росздрава; Центральная больница № 6 “ОАО” РЖД, МоскваМосковский государственный медико-стоматологический университет Росздрава; Центральная больница № 6 “ОАО” РЖД, МоскваМосковский государственный медико-стоматологический университет Росздрава; Центральная больница № 6 “ОАО” РЖД, МоскваМосковский государственный медико-стоматологический университет Росздрава; Центральная больница № 6 “ОАО” РЖД, МоскваHigh effectiveness and safety of beta-adrenoblockers (BB) in patients with coronary heart disease (CHD) have been proven by manifold clinical trials. BB are effective and safe, provided dose regimen is correct and contraindications are taken into account. BB significantly reduce total mortality and sudden cardiac death risk in CHD patients.https://cardiovascular.elpub.ru/jour/article/view/1505ишемическая болезнь сердцавнезапная сердечная смертьβ-адреноблокаторы
spellingShingle A. E. Radzevich
A. G. Evdokimova
A. Yu. Konyakhin
V. V. Popov
Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
Кардиоваскулярная терапия и профилактика
ишемическая болезнь сердца
внезапная сердечная смерть
β-адреноблокаторы
title Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
title_full Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
title_fullStr Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
title_full_unstemmed Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
title_short Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
title_sort beta adrenoblockers in coronary heart disease patients evidencebased medicine data
topic ишемическая болезнь сердца
внезапная сердечная смерть
β-адреноблокаторы
url https://cardiovascular.elpub.ru/jour/article/view/1505
work_keys_str_mv AT aeradzevich betaadrenoblockersincoronaryheartdiseasepatientsevidencebasedmedicinedata
AT agevdokimova betaadrenoblockersincoronaryheartdiseasepatientsevidencebasedmedicinedata
AT ayukonyakhin betaadrenoblockersincoronaryheartdiseasepatientsevidencebasedmedicinedata
AT vvpopov betaadrenoblockersincoronaryheartdiseasepatientsevidencebasedmedicinedata